You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

peripheral blood mononuclear cell transcriptomics

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Entecavir Versus Tenofovir on HBV DNA Level in Peripheral Blood

Not yet recruiting
  • Hepatitis B, Chronic
  • Detection of HBV-DNA in Peripheral Blood Mononuclear cells
  • (no location specified)
Dec 13, 2021

Infertility, Female, IVF Trial in Sofia (PBMC immunomodulated with IFNt)

Recruiting
  • Infertility, Female
  • IVF
  • PBMC immunomodulated with IFNt
  • Sofia, Bulgaria
    Nadezhda Women's Health Hospital
Mar 7, 2023

Toll-like Receptors 3 , 7 and 9 in Peripheral Blood Mononuclear

Not yet recruiting
  • COVID-19 Respiratory Infection
  • blood sample
  • (no location specified)
Oct 21, 2021

Minimal Residual Disease in Peripheral T-cell Lymphoma

Active, not recruiting
  • Peripheral T Cell Lymphoma
  • Tumor biopsy
  • +2 more
  • Boston, Massachusetts
  • +2 more
Dec 19, 2022

CX3CR1+T Cell Predict Immunotherapy Efficacy

Recruiting
  • Non-small Cell Lung Cancer
  • PD-1 inhibitor based immunotherapy
  • Changsha, Hunan, China
  • +1 more
Sep 19, 2023

Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

Active, not recruiting
  • Chronic Granulomatous Disease Transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

Active, not recruiting
  • Refractory Non Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • rituximab
  • +7 more
  • Sacramento, California
    University of California Davis
Nov 28, 2022

Graft Vs Host Disease, Graft-versus-host-disease, GVHD Trial in Saint Louis (Ruxolitinib)

Not yet recruiting
  • Graft Vs Host Disease
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 18, 2023

Peripheral Blood Neoantigen Specific T Cells Predict Efficacy of

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shanghai, Shanghai, China
      Cancer hospital Fudan University
    Nov 30, 2022

    Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

    Active, not recruiting
    • Plasma Cell Leukemia
    • +3 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 6, 2022

    Healthy Subject Trial in Shanghai (Peripheral blood mononuclear cell apheresis)

    Recruiting
    • Healthy Subject
    • Peripheral blood mononuclear cell apheresis
    • Shanghai, China
      Zhaxin Hospital of Integrated Traditional Chinese and Western Me
    Jun 7, 2021

    Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,

    Recruiting
    • Sickle Cell Disease
    • haploidentical stem cell transplant
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 18, 2022

    Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

    Recruiting
    • Sickle Cell Disease
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)

    Active, not recruiting
    • Plasma Cell Myeloma
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Nov 21, 2022

    Granulocyte Colony-stimulating Factor, Stem Cell Mobilization Trial (PEG-rhG-CSF)

    Not yet recruiting
    • Granulocyte Colony-stimulating Factor
    • Stem Cell Mobilization
    • (no location specified)
    Jun 13, 2022

    Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral

    Recruiting
    • Congenital Hemolytic Anemia
    • Sickle Cell Disease
    • Peripheral blood hematopoietic progenitor cell (PBPC) transplant
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    NSCLC Trial in Yichang (Sindillimab)

    Completed
    • Non-small Cell Lung Cancer
    • Yichang, Hubei, China
      Department of Medical Oncology, Central Hospital of Yichang City
    Mar 29, 2023

    Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

    Terminated
    Has Results
    • Acute Biphenotypic Leukemia
    • +29 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 4, 2023

    Multiple Myeloma, Lymphoma Trial in China (Etoposide, Cyclophosphamide, Mecapegfilgrastim, day 2)

    Recruiting
    • Multiple Myeloma
    • Lymphoma
    • Hefei, Anhui, China
    • +6 more
    Dec 1, 2022

    Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

    Completed
    Has Results
    • Leukemia
    • +2 more
    • CliniMACS Fractionation system (Arm A)
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 12, 2022

    Peripheral Blood Single Cell Sequencing Analysis of POD and CPSP

    Not yet recruiting
    • Postoperative Delirium
    • Chronic Postsurgical Pain
      • (no location specified)
      Oct 5, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +36 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jan 23, 2023

      Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

      Not yet recruiting
      • Leukemia, Acute
      • +7 more
      • (no location specified)
      Apr 10, 2023

      Complication Trial in Dongguan, Guangzhou (autologous cord blood mononuclear cells, normal saline)

      Recruiting
      • Complication
      • autologous cord blood mononuclear cells
      • normal saline
      • Dongguan, Guangdong, China
      • +1 more
      Oct 9, 2021

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +6 more
      • Duarte, California
        City of Hope Medical Center
      Dec 8, 2022